The Translational Research Institute’s fifth annual Research Day highlighted the pivotal role of translational science in Arkansas, showcasing research presentations, panel discussions, and a poster session focused on scientific impact. A keynote presentation was delivered by Barry Coller, M.D., the David Rockefeller Professor of Medicine and head of the Allen and Frances Adler Laboratory of…
The University of Arkansas for Medical Sciences (UAMS) recently became the first provider in Arkansas to receive a Center of Excellence designation for implantation of the AMS 800, a device that treats severe male stress incontinence caused by prostate cancer treatments. Brian Langford, M.D., a urologist at the UAMS Health Urology Center at Premier Medical…
On a recent Saturday morning at the University of Arkansas for Medical Sciences (UAMS) Simulation Center, six high school students gathered around a manikin that needed immediate medical attention.
The University of Arkansas for Medical Sciences (UAMS) has received a gift of $140,000 from Gary Clark, P.D., to increase the endowment of his family scholarship for the UAMS College of Pharmacy to a university scholarship.
The University of Arkansas for Medical Sciences (UAMS) hosted a topping out ceremony today for the UAMS Health Orthopaedics & Sports Medicine Hospital, which will be the new home of world-class orthopaedic and sports medicine care providers serving Northwest Arkansas.
Majid Asgari, Ph.D. Majid Asgari, Ph.D., is a postdoctoral fellow in the UAMS College of Medicine Department of Internal Medicine. He earned his doctorate in medical biotechnology from the Pasteur Institute of Iran in 2021 and joined the UAMS Myeloma Center in 2024 in the lab of research director Fenghuang “Frank” Zhan, M.D., Ph.D. His…
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages Blood Cancer Journal November 2024 Primary authors: Yan Cheng, Ph.D.; Fumou Sun, Ph.D. Tumor immune microenvironmental alterations occur early in multiple myeloma development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor-immune interactions from precursor stages,…
Five years after its opening, Infusion B at the Winthrop P. Rockefeller Cancer Institute continues to play a vital role in the transformational care that blood cancer patients receive at the University of Arkansas for Medical Sciences (UAMS).
Gary Robertson thinks his multiple myeloma diagnosis came at good time, if such a thing is possible.
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) is the state’s leader in cancer clinical trials. Clinical trials are conducted for purposes such as studying new drugs or drug combinations, reviewing a new method of performing surgeries or using existing treatments, or researching ways to prevent diseases.